These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 4102079

  • 1. Inhibition of cellular anaphylaxis by beta-stimulants.
    Martin LE.
    Postgrad Med J; 1971 Mar; 47():Suppl:26-30. PubMed ID: 4102079
    [No Abstract] [Full Text] [Related]

  • 2. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H, Kohno S, Ohata K.
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [Abstract] [Full Text] [Related]

  • 3. Studies of the 3,methoxy-derivatives of isoprenaline, isoetharine and WG 253 on isolated human tissue.
    Hornsey PA, Gailer KA, Turner P, Griffin JP.
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):357-64. PubMed ID: 4397369
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of in vivo and in vitro inhibition of the anaphylactic mechanism by beta-adrenergic stimulants and disodium cromoglycate.
    Assem ES, Richter AW.
    Immunology; 1971 Nov; 21(5):729-39. PubMed ID: 4107218
    [Abstract] [Full Text] [Related]

  • 5. [Experimental study on the action mechanism of a new bronchodilator agent, BB-1502].
    Kamei H, Obi Y, Kawano K, Hirano M, Murata S, Imanishi H.
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):335-42. PubMed ID: 6200410
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of histamine and SRS-A from monkey lung tissue by chlorophenesin.
    Malley A, Baecher L.
    J Immunol; 1971 Aug; 107(2):586-8. PubMed ID: 4105542
    [No Abstract] [Full Text] [Related]

  • 7. An introduction to salbutamol and other modern beta-adrenoreceptor stimulants.
    Jack D.
    Postgrad Med J; 1971 Mar; 47():Suppl:8-11. PubMed ID: 4396721
    [No Abstract] [Full Text] [Related]

  • 8. Endogenous broncho-active substances and their antagonism.
    Collier HO.
    Adv Drug Res; 1970 Mar; 5():95-107. PubMed ID: 4395356
    [No Abstract] [Full Text] [Related]

  • 9. Proceedings: The influence of glucocorticoids on the stimulability of adenyl-cyclase and the anaphylactic histamine release in the guinea pig lung in vitro.
    Schmutzler W, Poblete Freundt G.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Mar; 282(Suppl):suppl 282:R85. PubMed ID: 4135777
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacodynamic study of a new antiasthmatic drug. Salbutamol].
    Foussard-Blanpin O, Narcisse G.
    Therapie; 1971 Mar; 26(6):1081-96. PubMed ID: 4401716
    [No Abstract] [Full Text] [Related]

  • 11. Proceedings: Anaphylactic release of prostaglandins, slow-reacting substance, and histamine, and its modification by sympathomimetics.
    Liebig R, Peskar B, Bernauer W.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Mar; 282(Suppl):suppl 282:R58. PubMed ID: 4135775
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of the release of slow-reacting substance of anaphylaxis in the rat with diethylcarbamazine.
    Orange RP, Valentine MD, Austen KF.
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):127-32. PubMed ID: 4384569
    [No Abstract] [Full Text] [Related]

  • 13. The role of slow-reacting substance in asthma.
    Brocklehurst WE.
    Adv Drug Res; 1970 Jan; 5():109-13. PubMed ID: 4923800
    [No Abstract] [Full Text] [Related]

  • 14. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.
    Cox JS.
    Nature; 1967 Dec 30; 216(5122):1328-9. PubMed ID: 6080064
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S, Tanaka Y, Wagatsuma Y, Miura R, Umezu A.
    Arerugi; 1971 Aug 30; 20(8):599-609. PubMed ID: 4398383
    [No Abstract] [Full Text] [Related]

  • 16. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic releas of histamine an slow-reacting substance of anaphylaxis (SRS-A).
    Orange RP, Stechschulte DJ, Austen KF.
    J Immunol; 1970 Nov 30; 105(5):1087-95. PubMed ID: 4099046
    [No Abstract] [Full Text] [Related]

  • 17. Immunopharmacological studies on mydocalm and related compounds as an antagonist of slow reacting substance of anaphylaxis (SRS-A).
    Nagai H, Matsuura N, Sato N, Koda A, Kohno S.
    J Pharmacobiodyn; 1983 Nov 30; 6(11):874-80. PubMed ID: 6199492
    [Abstract] [Full Text] [Related]

  • 18. Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths).
    Conolly ME, Davies DS, Dollery CT, George CF.
    Br J Pharmacol; 1971 Oct 30; 43(2):389-402. PubMed ID: 4400573
    [Abstract] [Full Text] [Related]

  • 19. Comparison of effects of investigational compounds upon allergic phenomena in rodents in vivo and in human basophils in vitro.
    Mielens ZE, Magro A.
    Methods Find Exp Clin Pharmacol; 1982 Oct 30; 4(2):111-7. PubMed ID: 6181358
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological activity of biscoumarinoxy-, bis(1,2-benzisoxazoloxy) & bisbenzofuranoxy-alkanes & their unsymmetric compounds: disodium cromoglycate analogs.
    Thakar KA, Dumir AB.
    Indian J Exp Biol; 1978 Jun 30; 16(6):732-4. PubMed ID: 81180
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.